Michael J. McElhaugh
2022
In 2022, Michael J. McElhaugh earned a total compensation of $1.3M as Chief Operating Officer at Arbutus Biopharma Corp.
Compensation breakdown
| Non-Equity Incentive Plan | $147,200 |
|---|---|
| Option Awards | $708,610 |
| Salary | $448,750 |
| Other | $10,675 |
| Total | $1,315,235 |
McElhaugh received $708.6K in option awards, accounting for 54% of the total pay in 2022.
McElhaugh also received $147.2K in non-equity incentive plan, $448.8K in salary and $10.7K in other compensation.
Rankings
In 2022, Michael J. McElhaugh's compensation ranked 2,501st out of 5,759 executives tracked by ExecPay. In other words, McElhaugh earned more than 56.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,501 out of 5,759 | 57th |
Division Manufacturing | 1,376 out of 3,135 | 56th |
Major group Chemicals And Allied Products | 622 out of 1,421 | 56th |
Industry group Drugs | 576 out of 1,322 | 56th |
Industry Pharmaceutical Preparations | 413 out of 968 | 57th |
Source: SEC filing on April 12, 2023.
McElhaugh's colleagues
We found two more compensation records of executives who worked with Michael J. McElhaugh at Arbutus Biopharma Corp in 2022.